跳至主要内容
临床试验/NCT00670436
NCT00670436已完成2 期

The Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery Disease to Treat Chronic Total Occlusions

University of Ulm4 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2008年2月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
48
试验地点
4
主要终点
Late loss

研究概览

简要总结

The aim of the study is to assess the safety and efficacy of a Paclitaxel-eluting PTCA-balloon in combination with bare-metal stenting for treatment of chronic total occlusions in native coronary arteries with reference diameters between 2.5 mm and 4.0 mm.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • chronic total occlusion
  • Thrombolysis in Myocardial Infarction (TIMI) flow 0 or 1
  • occlusion in native coronary artery
  • indication for percutaneous coronary intervention based on symptoms, prognosis or evidence of ischemia
  • reference diameter 2.5 mm to 4.0 mm

排除标准

  • saphenous vein graft
  • bifurcation lesion with need to stent main and side branch
  • left main occlusion
  • de-novo stenosis (no occlusion)
  • restenosis
  • in-stent restenosis
  • contraindication for dual antiplatelet therapy with acetylsalicylic acid and clopidogrel for 6 months
  • coronary aneurysm at target lesion

结局指标

主要结局

Late loss

时间窗: 6 months

次要结局

  • percent diameter stenosis(6 months)
  • late loss index(6 months)
  • target vessel revascularization(30 days, 6, 12, 24 months)
  • major adverse cardiac events(30 days, 6, 12, 24 months)
  • binary angiographic restenosis rate(6 months)
  • Target lumen revascularization(30 days, 6, 12, 24 months)

研究者

发起方
University of Ulm
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jochen Wohrle

Prof. Dr. Jochen Wöhrle

University of Ulm

研究点 (4)

Loading locations...

相似试验